Cancer Biopsy Market Growth Accelerated by Advancements in Biopsy Devices
![]() |
| Cancer Biopsy Market |
Cancer biopsy involves obtaining a tissue sample from patients to determine whether cancer is present or not. It helps physicians to diagnose cancer subtype and develop an appropriate treatment plan. Advancements in biopsy devices have made the procedures less invasive and painful for patients. Components such as disposable probes and needles have improved tissue sampling.
The global Cancer Biopsy Market is estimated to be
valued at US$ 25.61 Bn in 2023 and is expected to exhibit a CAGR of 13.% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
Advancements in Biopsy Devices
The market has observed significant advancements in biopsy devices over the
past few years. Manufacturers are focusing on developing biopsy devices with
advanced features such as ergonomic designs, tissue visualization, and
automated operations. For instance, companies are offering biopsy devices
equipped with ultrasound guidance that allows physicians to visualise tissues
in real-time and extract targeted samples. Some devices are integrated with
advanced robotics to automate the biopsy process, reducing procedural time and
errors. The growing technological advancements are expected to drive the
adoption of biopsy devices, thereby accelerating the market growth over the
forecast period.
Segment Analysis
The global cancer biopsy market is segmented by product type, application, end
user, and geography. By product type, the market is dominated by needles
segment as it is widely used for sampling tissues. Needles are further divided
into fine-aspiration needles, core needles, and vacuum-assisted biopsy needles.
Core needles sub segment dominates as it helps in obtaining intact tissue
sample.
Key Takeaways
The global Cancer
Biopsy Market Size is expected to witness high growth over the forecast
period of 2023 to 2030.
Regional analysis: North
America region currently dominating the market due to early adoption of
advanced biopsy devices and techniques. The growth in Asia Pacific region is
expected to be the fastest during the forecast period due to increasing
healthcare expenditure and growing penetration of biopsy devices in countries
like China, India.
Key players operating in the cancer biopsy market are Atlassian Corporation
Plc, Microsoft Corporation, Monday.com Ltd., Wrike, Inc., Asana, Inc., Jira
Software (part of Atlassian), Smartsheet Inc., Trello, Inc., Basecamp LLC,
Teamwork.com Ltd., Zoho Corporation Pvt. Ltd., Pivotal Software, Inc.,
VersionOne Inc., Clarizen Ltd., Targetprocess Inc.
Check below related articles on this topic : https://www.newsanalyticspro.com/cancer-biopsy-market-growth-driven-by-rising-demand/

Comments
Post a Comment